Balanced news tone
News Sentiment
LLY sentiment intelligence
Eli Lilly and Company news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
86/100 classification confidence.
directly relevant articles
high-authority source matches
-0.2% over one week, +12.0% over four weeks, trend active, and near fair-value range.
Eli Lilly Stock Hovers In Buy Zone, Finds Key Support Amid $3 Billion Deal
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Eli Lilly Stock Slides Amid Rising Industry Headwinds
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Feb 2026 08:00
- Source
- Evrim Ağacı
3 Reasons A Pullback In Eli Lilly Stock Is Likely
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Feb 2026 08:00
- Source
- Forbes
Eli Lilly Stock Price (LLY) Holding On To $1000 Ahead of Earnings – What Next?
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 04 Feb 2026 08:00
- Source
- AskTraders
Eli Lilly Stock To $1,330?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Nov 2025 08:00
- Source
- Forbes
Is Eli Lilly Stock’s Run Too Hot? Here Is How It Can Crash
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Nov 2025 08:00
- Source
- Forbes
Eli Lilly and Company (LLY) Unveils AI Platform to Enhance Drug Discovery
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Sep 2025 07:00
- Source
- Market source
Eli Lilly’s shares up as oral GLP-1RA scores in first Phase III trial
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Apr 2025 07:00
- Source
- Clinical Trials Arena